Anzeige
Mehr »
Login
Freitag, 29.03.2024 Börsentäglich über 12.000 News von 687 internationalen Medien
Spezial am Donnerstag: Rallye II. - Neuer Anstoß, News und was die Börsencommunity jetzt nicht verpassen will…
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: 883035 | ISIN: US8816242098 | Ticker-Symbol: TEV
Tradegate
28.03.24
18:58 Uhr
13,000 Euro
-0,100
-0,76 %
Branche
Pharma
Aktienmarkt
Sonstige
1-Jahres-Chart
TEVA PHARMACEUTICAL INDUSTRIES LTD Chart 1 Jahr
5-Tage-Chart
TEVA PHARMACEUTICAL INDUSTRIES LTD 5-Tage-Chart
RealtimeGeldBriefZeit
13,05013,15028.03.
13,05013,15028.03.

Aktuelle News zur TEVA Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
DoTeva UK and Closed Loop Medicine partner to advance development of personalised medicines13
MiSpotlight on Teva Pharmaceutical Indus: Analyzing the Surge in Options Activity29
MiTeva on track for seventh straight day of gains16
MiTeva UK partners Closed Loop on personalised medicine12
DiTeva UK and Closed Loop Medicine Announce Strategic Partnership to Advance Development of Personalised Medicines390Teva UK Limited and Closed Loop Medicine Ltd have announced a strategic partnership to advance the development of personalised medicines. Under the agreement, Closed Loop Medicine a leading TechBio...
► Artikel lesen
MoFTC Intervenes in Teva's Inhaler Litigation Against Amneal Amid Patent Crackdown11
MoFTC weighs in on Teva's asthma inhaler litigation against Amneal amid far-reaching patent crackdown40
11.03.Teva Pharma shares target raised to $17 on growth strategy120
11.03.FDA rejects Mapi-Viatris long-acting version of Teva's Copaxone52
11.03.FDA rejects Viatris/Mapi long-acting version of Teva's Copaxone33
08.03.Teva upgraded at J.P. Morgan on upcoming catalysts54
08.03.JPMorgan upgrades Teva stock, raises target to $14 amid pipeline progress43
04.03.Teva slammed for breaching drug promotion code in earned media article41
01.03.UroGen slips as Teva seeks FDA nod for Jelmyto generic48
27.02.Nasenspray, Fiebersaft, Zäpfchen: Kinderarzneimittelliste: Ibu ohne Ratiopharm53
26.02.Humira biosimilar from Alvotech, Teva wins FDA approval on third attempt41
26.02.Teva teams up with Nhwa for AUSTEDO distribution in China15
26.02.TEVA Stock Pops 4% as Teva Receives FDA Approval20
26.02.Why Is Generic Drugs Player Teva Pharma Stock Trading Higher Today?21
26.02.FDA approves Alvotech and Teva's Simlandi as interchangeable Humira biosimilar20
Seite:  Weiter >>
235 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,11